Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE4
Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
- Status
- TERMINATED
- Phase
- N/A
Canadian Pegvisomant Compassionate Study In Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE4
Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.
- Status
- COMPLETED
- Phase
- PHASE3
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.
- Status
- COMPLETED
- Phase
- PHASE3
To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.
- Status
- COMPLETED
- Phase
- PHASE3
Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics
- Status
- COMPLETED
- Phase
- PHASE2
Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients
- Status
- COMPLETED
- Phase
- PHASE3
Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in Japan
- Status
- COMPLETED
- Phase
- PHASE3
An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
- Status
- COMPLETED
- Phase
- PHASE3
A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation.
- Status
- COMPLETED
- Phase
- PHASE2
A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation
- Status
- COMPLETED
- Phase
- PHASE2
12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation
- Status
- COMPLETED
- Phase
- PHASE2
A First In Human Study Of PF-00184562 In Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)
- Status
- COMPLETED
- Phase
- PHASE3
Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke
- Status
- COMPLETED
- Phase
- PHASE4